Daito Pharmaceutical Co., Ltd.【JP:4577】Cash flow
Market cap
¥41B
P/E ratio
17.8x
| 2015/05 | 2016/05 | 2017/05 | 2018/05 | 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | |
| Depreciation & amortization | 2,440 | 2,643 | 2,818 | 2,853 | 2,853 | 2,950 | 3,154 | 3,313 | 3,870 | 3,659 | 4,332 |
| Cash from operations | 3,739 | 2,949 | 5,070 | 5,465 | 6,888 | 4,306 | 5,183 | 4,370 | 4,155 | 5,182 | 5,897 |
| Capital expenditures | -4,919 | -3,949 | -2,992 | -3,822 | -3,630 | -2,731 | -6,319 | -4,627 | -5,505 | -6,220 | -6,789 |
| Cash from investing | -4,595 | -4,015 | -3,012 | -3,833 | -3,867 | -2,681 | -6,324 | -4,400 | -5,566 | -5,930 | -7,365 |
| Payments for dividends | -466 | -375 | -375 | -413 | -451 | -502 | -658 | -660 | -931 | -907 | -998 |
| Repurchases of common stock | -8 | -2 | -1 | -1 | -0 | -0 | -0 | - | -110 | -1,176 | -623 |
| Proceeds from issuance of term debt, net | 1,800 | 2,500 | 2,300 | 2,500 | 1,000 | - | 2,000 | 1,500 | 3,000 | 4,000 | 6,000 |
| Repayments of term debt | -2,632 | -2,622 | -2,335 | -2,265 | -2,039 | -1,852 | -1,712 | -1,444 | -1,638 | -2,029 | -3,099 |
| Cash from financing | 503 | 526 | -1,778 | -1,544 | -2,898 | -350 | 1,425 | 989 | 616 | -183 | 1,002 |